Dr. James Eubanks was awarded $25,000 in 2016 for his study: Testing new read-through drugs for prospective treatment of Rett Syndrome.
In 2019, Dr. Eubanks was awarded a second grant of $50,000 for his project entitled A Preclinical Trial In MeCP2-Deficient Mice To Test The Repurposing Potential Of An FDA-Approved Drug For Use In Rett Syndrome.
Last Updated: 07/24/2021 by Bryan Higgins
Dr. James Eubanks
Dr. James Eubanks was awarded $25,000 in 2016 for his study: Testing new read-through drugs for prospective treatment of Rett Syndrome.
In 2019, Dr. Eubanks was awarded a second grant of $50,000 for his project entitled A Preclinical Trial In MeCP2-Deficient Mice To Test The Repurposing Potential Of An FDA-Approved Drug For Use In Rett Syndrome.